New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...

The FDA has approved Rybrevant plus chemotherapy in certain patients with locally advanced or metastatic non-small cell lung ...

Johnson & Johnson said the Food and Drug Administration approved its treatment of locally-advanced or metastatic non-small cell lung cancer for adults. The treatment, called Rybrevant, has been ...

A phase 3 trial of Daiichi Sankyo and Merck & Co.’s HER3-directed antibody-drug conjugate (ADC) has hit its primary endpoint, ...

Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma ...

A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that ...

Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...

“They suspected lung cancer,” said lung cancer awareness advocate Matthew Koebbe. “We did a biopsy, and confirmed that, yes, ...

Joshua Ray Walker let fans know this week that Thursday is slated to be a big day for him in his battle against cancer. The ...

Treatment of non-small cell lung cancer (NSCLC) depends on the stage you're in and can include chemotherapy, surgery, ...

The LUNG FORCE Run/Walk provides critical funds for lifesaving lung cancer research, early detection initiatives and ...